LIF and cancer: Studies have shown that different cell lines of the same cancer type can have vastly different baseline levels of LIF expression [86], so use of multiple cell lines is important for ensuring translatability, as patients also are likely to have highly heterogenous tumors, and medicine is becoming more personalized.